SynAct Pharma AB (OSTO:SYNACT) Common Stock: kr7.03 Mil (As of Mar. 2026)


OSTO:SYNACT SynAct Pharma AB OSTO:SYNACT
18 GF Score
Price kr19.30
! 1 Warning Sign
View Full Analysis

What is SynAct Pharma AB Common Stock?

SynAct Pharma AB OSTO:SYNACT +0.42% 18 Common Stock is kr7.03 Mil as of Mar. 2026. GuruFocus rates OSTO:SYNACT with a GF Score™ of 18/100. The stock has 1 warning sign investors should review.

SynAct Pharma AB's quarterly common stock stayed the same from Sep. 2025 (kr6.67 Mil) to Dec. 2025 (kr6.67 Mil) but then increased from Dec. 2025 (kr6.67 Mil) to Mar. 2026 (kr7.03 Mil).

SynAct Pharma AB's annual common stock increased from Dec. 2023 (kr4.45 Mil) to Dec. 2024 (kr5.81 Mil) and increased from Dec. 2024 (kr5.81 Mil) to Dec. 2025 (kr6.67 Mil).

SynAct Pharma AB Common Stock Historical Data

* Premium members only.

The historical data trend for SynAct Pharma AB's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

SynAct Pharma AB Common Stock Chart

SynAct Pharma AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Common Stock
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.25 3.71 4.45 5.81 6.67

SynAct Pharma AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.13 6.23 6.67 6.67 7.03
OSTO:SYNACT
18GF Score
SynAct Pharma AB OSTO:SYNACT
Common Stock is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

SynAct Pharma AB Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Frequently Asked Questions Learn more about Common Stock →
What does a Common Stock of kr7.03 Mil mean?
SynAct Pharma AB (OSTO:SYNACT) has a Common Stock of kr7.03 Mil as of Mar. 2026. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on SynAct Pharma AB and its competitors.
Is SynAct Pharma AB's Common Stock too high?
SynAct Pharma AB's current Common Stock is kr7.03 Mil. Overall, SynAct Pharma AB has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does SynAct Pharma AB's Common Stock compare to VRTX and REGN?
SynAct Pharma AB's Common Stock of kr7.03 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Common Stock for a Biotechnology company?
A good Common Stock depends on the Biotechnology industry context. However, Common Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Common Stock mean?
A high Common Stock can signal that a stock is expensive relative to its fundamentals. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on SynAct Pharma AB and its competitors. SynAct Pharma AB's current Common Stock is kr7.03 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SynAct Pharma AB stock overvalued right now?
SynAct Pharma AB (OSTO:SYNACT) has a current Common Stock of kr7.03 Mil. The current Common Stock is kr7.03 Mil. SynAct Pharma AB's overall GF Score™ is 18/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Common Stock calculated?
Common Stock is calculated from a company's financial statements. For SynAct Pharma AB (OSTO:SYNACT), the current Common Stock is kr7.03 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

SynAct Pharma AB Business Description

Other Exchanges 8F8:Germany
Address Scheelevagen 2, Lund, SWE, 223 63
SynAct Pharma AB is a clinical-stage biotechnology company focused on resolving inflammation through the selective activation of the melanocortin system. The company has a broad portfolio of oral and injectable selective melanocortin agonists aimed at inducing anti-inflammatory and inflammation-resolution activity to help patients achieve immune balance and overcome inflammation. AP1189, the company's drug candidate, is being evaluated in three Phase 2 clinical programs regarding rheumatoid arthritis, idiopathic membranous glomerulonephritis and virus-induced respiratory failure.
18GF Score

Get the complete analysis for OSTO:SYNACT

Common Stock is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr19.30
Price